Cardiology

A discussion into available pharmacotherapy for obesity and the uptake in practice of newer agents.

These findings suggest the importance of COVID-19 vaccination for patients with OHT.

The prevalence of sleep-disordered breathing differed across various etiologies of heart failure.

There was no statistically significant difference in mean systolic blood pressure for the self-monitoring groups vs the usual care group.

Treating 100 older patients (≥60 years) with hypertension for approximately 3 years would prevent 1 major adverse cardiovascular event.

Sleep disordered breathing is frequently cited in patients with heart failure due to multiple factors included hypoxemia, sympathetic activation and systematic inflammation.

The study authors used data from Medicare beneficiaries who survived a heart attack between 1995 and 2019.

Investigators observed no reduction in readmission or mortality in a remote monitoring program with incentives for patients previously hospitalized for HF.

The Massachusetts General Hospital investigator discusses how LVADs and mechanical circulatory supports have altered the national heart donor strategy.

The rate of long-term survival after 10 years in patients surviving the initial hospital stay after OHCA was between 62% and 64%.

Jennifer Green discussed weight management and obesity during the annual Pri-Med West conference.

Type 2 diabetes can be more aggressive in younger patients.

There is concern for cardiovascular patients over missed screenings during the pandemic.

The pandemic has removed some of the barriers of medicine.

Phone communication may have decreased in recent years among doctors.

Expert cardiologists discuss CAD guidelines and approaches to management of patients with polyvascular disease.

Dr Sahil Parikh and other experts discuss engagement of cardiologists in patients diagnosed with polyvascular disease and challenges in screening patients.

Steve R. Ommen, MD, leads a review of common mutations seen in hypertrophic cardiomyopathy and the role of biomarkers and genetic testing in HCM.

Martin S. Maron, MD, discusses the incidence and prevalence of hypertrophic cardiomyopathy and age of disease expression.

Data show 7 risk factors, many potentially modifiable, accounted for 85% of the risk of first AMI in young women and men.

Dapagliflozin was associated with reducing the primary composite endpoint of CV death or worsening HF in patients with HF with mildly reduced or preserved ejection fraction.

The participants included more than 2,000 pregnant individuals at higher risk of preeclampsia.

Study investigators used data from midlife checkpoints and late life checkpoints for participants without heart failure.

Dr Amy Pollak and other experts discuss their recommendations for screening for CAD and PAD in asymptomatic patients.

Drs Marc Bonaca and Manesh Patel provide an overview of Polyvascular Disease and prevalence of coronary artery disease and peripheral artery disease.

The first in-class myosin inhibitor is supported by findings from the pivotal EXPLORER-HCM trial for patients with the rare condition.

The decision to initiate low-dose aspirin use for CVD prevention in adults aged 40 to 59 years with a 10% or greater 10-year CVD risk should be individualized.

Data show 15-mg edoxaban dose was superior to placebo in preventing stroke or systemic embolism in all 3 age strata studied, with higher incidence of major bleeding.

The 2022 State of the Air report from the American Lung Association highlights growing disparities in coastal-based ozone and particle pollution, amid wildfires and shifts in regulatory policies.

Individuals in the intervention arm walked a mean of 647 more steps per day compared with the control arm.